WO1989007135A1 - Bovine embryo in vitro culture - Google Patents
Bovine embryo in vitro culture Download PDFInfo
- Publication number
- WO1989007135A1 WO1989007135A1 PCT/US1988/004700 US8804700W WO8907135A1 WO 1989007135 A1 WO1989007135 A1 WO 1989007135A1 US 8804700 W US8804700 W US 8804700W WO 8907135 A1 WO8907135 A1 WO 8907135A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- embryos
- bovine
- culture
- vitro
- oviductal
- Prior art date
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 63
- 238000000338 in vitro Methods 0.000 title claims abstract description 38
- 210000001161 mammalian embryo Anatomy 0.000 title claims description 13
- 210000002257 embryonic structure Anatomy 0.000 claims abstract description 90
- 238000000034 method Methods 0.000 claims abstract description 34
- 210000002459 blastocyst Anatomy 0.000 claims abstract description 24
- 239000012530 fluid Substances 0.000 claims abstract description 15
- 239000000725 suspension Substances 0.000 claims abstract description 15
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 239000003855 balanced salt solution Substances 0.000 claims abstract description 13
- 210000000472 morula Anatomy 0.000 claims abstract description 13
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 238000012258 culturing Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 241000940612 Medina Species 0.000 claims 1
- 238000004114 suspension culture Methods 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 abstract description 20
- 235000020776 essential amino acid Nutrition 0.000 abstract description 18
- 238000011161 development Methods 0.000 abstract description 15
- 230000018109 developmental process Effects 0.000 abstract description 15
- 238000012546 transfer Methods 0.000 abstract description 9
- 230000009261 transgenic effect Effects 0.000 abstract description 4
- 238000012136 culture method Methods 0.000 abstract 1
- 230000013020 embryo development Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 44
- 210000004027 cell Anatomy 0.000 description 24
- 239000001963 growth medium Substances 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 241001494479 Pecora Species 0.000 description 6
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- 238000003501 co-culture Methods 0.000 description 4
- 230000004720 fertilization Effects 0.000 description 4
- 210000003101 oviduct Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940104230 thymidine Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- -1 Amino Acids Amino Acids Chemical class 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 206010016825 Flushing Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000000215 ciliated epithelial cell Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000005550 amino acid supplement Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000012913 medium supplement Substances 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 238000010449 nuclear transplantation Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001573 trophoblastic effect Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A culture method and system has been realized for in vitro development of bovine embryos from early stage 1- to 2-cell embryos to morula or blastocyst stage. The embryos are placed in a culture system of a buffered balanced salt solution with a carbohydrate energy source medium and bovine oviductal epithelial cells in suspension. Embryo development is enhanced by the addition of bovine or ovine oviductal fluid as well as non-essential amino acids to the system. The method and system can be used to culture genetically manipulated embryos used in transgenic procedures and nuclear transfer.
Description
BOVINE EMBRYO IN VITRO CULTURE Baci:cround of the Invention The in vitro culture of embryos of domestic animals has been studied and is of interest particularly with new techniques of genetic manipulation of early stage embryos. In vitro culture involves removing an egg from the animal' reproductive tract. Fertllization can occur before cr aft±: removal. Later stage embryos are also cultured In vItro which have been removed from the animal at a time after fertilization. The removed embryos are then placed in a culture medium for further development. A number of domestic and laboratory animal embryos have been used for in vitro culture experiments. Wright and Bondioli, "Aspects of In Vitro Fertilization and Embryo Culture in Domestic Animals," J. Anim. Sci., vol. 53, No. 3, pp.702-729 (1981). The embryos have been removed at very early stages, 1- to 2-cell, and later uterine stages, around 32-cell, and cultured in vitro. Generally a high proportion of the later stage embryos from domestic and laboratory animals will develop in vitro to a blastocyst stage and many till hatch from the zona pellucid. In bovine in vitro culture a "blocking" phenomenon has been observed at the 8- to 16-cell stage when culturing from 1-cell embryos. ante, "Culture Media and Culture of Early Embryos, Theriosenology, vol. 27, No. 1, pp. :.9-57 (1987); Eyestone and First, "A Study of the 8- to 16-Cell Developmental Block in Bovine Embryos Cultured In itro," Therioaenoloay, vol. 25, No. 1, p. 152 (1986). The bovine embryos generally fail to develop past the 8- to 16-cell stage to the blastocyst stage when cultured in tissue culture media wit various supplements. In one study 2- and 8-cell stage embryos were cultured in a various media. The 8-cell embryos were successfully cultured to blastocyst stage in vitro in selected medium, however none of the 2-cell embryos underwent more than one complete cell division in vitro. right et awl., "Successful Culture In Vitro cf Bovine Embryos to the Blastocyst Stage, Biol. ReDrod., vol. 14, pp.157-162 (1976). In another study, three of twenty-two i- to 2-cell stage bovine embryos cultured in medium developed into blastocysts, but this work has not been reportedly reproduced. Wight et al., "Blastocyst Expansion and Hatching of Bovine Ova Culture In vitro," J. Anim. Sci., vol. 43, p.170 (1976). The conventional method of culturing bovine embryos which hare been removed at the 1- te 2-cell stage is to transfer the embryo to a sheep oviduct for in vivo culture which overcomes the blocking observed in vitro. The embryos are later flushed from the sheep oviduct and transferred to recipient cow. The conventional method of bovine embryo culture involves the additional steps of culturing for a period of time in sheep, removal from sheep and re-introduction into the recipient cow. During the course 0 the transfers, there can be damage to or loss of the embryos. Another alternative for culturing bovine embryos is 2 co-culture system which includes the use ot a layer of cells cultured from embrvonic or adult tissue with a culture medium. The co-culture technique has promoted successful development for early stage embryos. However, the success rate for development to blastocyst or morula is higher when culturing embryos older than 1- to 2-cell. Camous et al, "Cleavage Beyond the Block Stage and Survival After Transfer of Early Bovine Embryos Cultured With Trophoblastic Vesicles", J. Repro. Fert., vol. 72, pp. 479-485 (1984) . In some cases, co-culture systems have been used only with bovine embryos at the 4-cell and older stages. Eyestone et al, "Co-Culture of Early Bovine Embryos With Oviductal Epithelium", Therioaenolocy, vol. 27, No. 1, p. 228 (1987). Summary of the Invention The present technique and components realize a system which cultures in vitro a substantial percentage of early stage bovine embryos to morula and blastocyst stage. The system uses a culture medium of buffered balanced salt solution with a carbohydrate energy source and bovine oviductal epithelial cells in a suspension. The early stage, 1- to 2-cell embryos are collected and placed in a drop of the medium with about 5% to 15% volume of cells in the fluid medium. The culture system drop is covered under a film such as silicone or paraffin oil. The suspension system is incubated at about 38 CC. in a 5 CO and 95% air humidified atmosphere. The cells develop to blastocyst stage in about seven days. At this point the embryos can be transferred to a recipient cow by non-surgical means. The culture medium can be supplemented with amino acids, growth factors and vitamins. The addition of non-essential amino acids increases the development rate of the embryos. The culture system may be supplemented with oviductal fluid from bovine or ovine. The oviductal fluid is mixed with the culture medium. A ':1 ratio of culture medium and oviductal fluid with the bovine oviductal epithelial cells system produces a substantial percentage of early stage embryos developing into blastocysts. The system of this invention can be used for bovine embryos and eggs that are subject to genetic research. In the nuclear transplantation studies, the genetic material from a selected cell is transferred with an egg that has been subjected to an enucleation procedure. The egg with the new genetic material is fused and cultured. Using the system of this invention, the culture process can be in vitro and the embryos can be observed during the critical early stages. For the nuclear transfer procedures, a system with demonstrated success for culturing 1-cell throuch blastocyst is 2 necessity. After the embryos are cultured, they may be transferred to recipient cows as desired. Similarly for research involving gene transfer, an in vitro system which is successful with early stage embryos is needed. In gene transfer work, foreign DNA is inserted into the nuclear material of preferably l-cell embryos. A culturing method is then used to grow the embryo to determine whether a transgenic embryo develops with the foreign gene incorporated and expressed. An in vitro technicue would allow the investigator to observe which embryos were developing and make further determination of the progress of culture. Description of the Preferred Methods and EmbodIment The following is a description of the preferred method and alternatives for culturing in vitro bovine embryos. The procedures have been used to culture early stage embryos from 1- and 2-cell until development to the morula or blastocyst stage. The techniques were utilized with early stage embryos used for transgenic research, the introduction of foreign DNA with the bovine embryo, and nuclear transfer research wherein nuclear donor material was transferred to an enucleated egg. The method was also used to develop bovine embryos which were not subject to any genetic manipulatIon. The method is successful for in vitro culture of manip- ulated and non-manipulated bovine embryos from the 1-cell stage to past the 8- to 16-cell stage. The preferred method and culture system utilizes a buffered balanced salt solution with a carbohydrate energy source medium. The balanced salt solution includes inorganic salts maintained at a physiological pH by a bicarbonate -CO2 buffer system. The carbohydrate energy source can include glucose, lacate, pyruvate or acetate. A medium of choice was Brinsters Mouse ova culture medium modified by the addition of sodium acetate and supplemented with bovine serum albumin. The medium was also supplemented with essential amino acids, non-essential amino acids and a combination of essential and non-essential amino acids. The components of the medium with non-essential amino acids included are listed in Table 1. Table 1 PREFERRED CULTURE MEDIUM FOR IN VITRO CULTURE OF BOVINE EMBRYOS Grams/Liter Unless Component Otherwise Noted NaCl 5.546 KC1 .356 CaCl2H2O .250 KH2PO4 .162 MgSO4.7H2O .294 NaHC03 2.106 Glucose 1.000 Na Lactate 3.6 ml of 60% syrup Na Pyruvate .056 EDTA .034 Na Acetate .050 Phenol Red 1 ml of .05t solution L-Alanine* 8.9 mg/l =-Asparagine H20* 15.0 mg/1 L-Aspartic Acid* 13.30 mg/l L-Glutamic Acid* 14.70 mg/l Glycine* 7.5 mg/1 L-Proline* 11.50 mg/l L-Serine* 10.50 mg/1 bovine serum albumin 6.0 mg/l penicillin 10,000 units/l strep-tomycin 10,000 mcg/1 *Non-essential amino acids. The basic culture medium was the components listed in Table 1 less the non-essential amino acids. The preferred method utilizes bovine oviductal epithelial cells in the culture system which are recovered from oviductal flushings when early stage embryos are recovered. The cells chosen are predominantly ciliated epithelial cells. The oviductal ciliated epithelial cells are washed ounce in phosphate buffered saline by allowing the clumps of cells to settle in a tube. The cells were then watched twice in culture media by pipetting. The cells were generally used the same d of collection. The cells have been fro=en and stored in liquid nitrogen and used successfully after storage. The culture system can be comprised of a mixture of the buffered balanced salt with a carbohydrate energy source medium and the cells. A 25 ul drop of medium will have about 5E to 15% by volume cf cells or about 2 to 4 s of cells added to the drops in a suspension-type system In the preferred method oviductal fluid collected from a cow or sheep is part of the culture system along wIth the medium and cells. In some cases a superovulated cow which had occulted oviducts produced a large amount fluid which had accumulated. ; superovulated animal was listed surgically on one or both ends of the oviduct and fluid was recovered. The bovine oviductal fluid (BOF) was recovered in a sterile manner. Any cellular debris was removed by centrifugation. The BOF can be frozen until utilized. Sheep oviductal fluid has been used with some success. In the preferred method and preferred culture sstem a 1:1 mixture of medium described in Table 1 and BOF is used. The amount -of BOF can be decreased since medium alone can be used A culture drop of 25 > 1 of the mixture with 2 ul of loosely packed cells added make up a drop of the culture system. The embryos were placed in a drop of the culture system. Preferably 1 to 10 embryos are contained in one drop. The embryos were washed once in a drop of the culture mixture before being placed in the culture drop. The culture system drop is covered with a film of paraffin, silicone oil or other inert covering. The culture system with embryos is kept at about 38"C under a 5% CO2 and 95% air humidified system. Larger volume culture drops of 1 ml or higher can be used. With a larger culture drop the oil covering can be omitted if desired. The oil covering is used to prevent evaporation of medium from a small volume. The culture is maintained for seven days during which time the normally developing embryos will be at the morula cr blastocyst stage. The embryos can be transferred non surgically to recipient cows for full development. The development to blastocysts, approximately 60 to 100 cells, exceeds the previously reported "blocking" in bovines at the 8- to 16-cell stage. This procedure has been used to culture embryos that have not been the subject of any manIpulation to determine the successful development from l-cell to blastocyst stage. Separate experiments were run with combinations of medium (as shown in Table 1 with and without the non-essential amino acids listed therein), BOF and cells in the culture system. In these experiments, it is not possible to determine at a 1-cell stage whether fertilization has been successful so that failure of development due to lack of fertilization can occur. The following Table 2 shows the results of the in vItro method and various culture systems. The development was termnated after seven days of culture to record the cellular count. Table 2 CULTURE SYSTEM RESULTS Medium Medium, Medium, Medium, Onlv Cells BOF BOF, Cells Number of Embryos 35 35 35 35 Percentage Developing After 7 Days 3% 43% 17% 608 The results show the development to the morula or blastocyst stage was greatest in the mixture of medium, BOF, and cells with 605 of the embryos developing. A system o medium and the cells showed a 43E development to morula cr blastocyst stage. The culture medium was varied to include combinations of essential and non-essential amino acids, vitamins and other additives as described below. A culture medium with the basic components of Table 1 (components of Table 1 less the non-essential amino acids) plus all of the essential and non-essential amino acids listed in Table 3 below was prepared. Table 3 COMBINED ESSEttTIAL AND NON-ESSENTIAL AMINO ACIDS Amino Acid m/1 of medium L-alanine g.o L-arginine HC1 211.0 L-asparaglne-H20 15.01 L-aspartic acid 13.0 L-cysteine 25.0 L-glutamic acid 14.7 L-glutamine 146.0 Glycine 7.51 L-histidine HC1-H20 23.0 L-isoleucine 2.6 L-leucine 13.0 L-lysine HC1 29.0 L-methionine 4.e8 L-phenyl alanine 5.0 L-proline 11.5 L-serine 10.5 L-threonine 3.57 L-tryptophan .6 L- rosine 1.81 L-valine 3.5 The basic culture medium was also supplemented with vitamins and other additives as shown In Table 4. Table 4 MEDIUM SUPPLEMENTS VITAMINS i OTHER ADDITIVES mo/1 Hypoxanthine 4.o Lipoic acid .2 Thymidine .7 Biotin .024 D-Ca: Pantothenate .715 Choline chloride .698 Folic acid 1.320 Inositol .541 Niacinamide .615 Pyridoxine-HCl .206 Riboflavin .376 Thiamine 1.0 Vitamin B12 1.36 Hypoxanthine, lipoic acid and thymidine are not generally considered vitamins but were included in this mixture referred to as a vitamin mixture. Hypoxanthine, a nucleotide precursor; thymidine, a nucleotide and lipcic acid, a coenzyme were also added. Systems using various culture media were tested with oviductal cells in suspension but without BOF. The media used were: (1) basic medium without any amino acids, (2) basic medium with vitamins (Table 4) , (3) basic medium with all amino acids in Table 3, and (4) basic medium with vitamins (Table 4) and all amino acids in Table 3. The results are reported in Table 5 showing the number of embryos developing to the morula or blastocyst stage. Table 5 (1) (2) (3) (4) No Amino Medium + Acids Medium + Medium + Vitamins t Medium Vitamins Amino Acids Amino Acids Number of Embryos 31 35 3 32 Number Developing 12 13 24 20 Percentage Developing 39% 37% 735 63% The results indicated that the development was improve when the medium is supplemented with amino acids. Additional culture systems were prepared using media supplemented with various amino acid mixtures and cells. The basic medium has the components listed in Table 1 less the non-essential amino acids. The various media tested were the basic medium of Table 1 plus essential and non-essential amino acids of Table 3. A medium was prepared with the basic medium of Table 1 and the essential amino acids used in MEM medium as shown in Table 6 below. Table 6 MEM ESSENTIAL AMINO ACIDS Amino Acids mg/l L-arginine HC1 126.40 L-cystine 24.0 L-histidir.e HC1-H20 42.00 L-isoleucine 2 52.50 L-leucine 52.40 L-lysir.e HC1 72.50 L-mezhionine 15.10 L-phenylalanine 33.00 L-threonine 47.60 L-tryptophan 10.20 L-tyrcsine 36.00 L-valine 46.80 The culture medium cf Table 1 includes the non-essential amino acids which are used in MEM tissue culture medium. Another medium was prepared combining the MEM essential and non-essential amino acids of Tables 1 and 6 with the other basic medium components of Table 1. The culturing method as described herein was followed using the various media and oviductal cells in the suspension system. Table 7 records the results of culture in vitro to morula or blastocyst stage for bovine embryos. Table 7 CULTURE RESULTS AMINO ACID SUPPLEMENTS Basic Basic Medium Medium Basic + MEM + All Medium + Essential ME.w Amino Amino Acids Medium Amino Acids Acics Table 3 Table i Table 6 Tables l;ó Number of Embryo 26 27 27 25 Number Developing 10 1t9 9 11 Percentage Developing 39E 70% 33% 44 The medium of Table 1 with the non-essential amino acids of MEM medium exhibited the best results. The in vitro development technique has been used for bovine embryos that have been subject to transgenic proce- dures. In these cases the pronucleus of a presumably fertilized embryo was injected with various foreign DNAs to determine if the foreign gene could be incorporated and expressed. The injection of foreign DNA can be lethal to the embryo. Also, not all embryos are fertilized. The injected embryos were cultured according to the preferred method in a system including medium of Table 1 in a 1:1 ratio with BOF and about 2 ul of cells in a suspension. About 25% of the embryos developed to morula or blastocysts. Upon transfer to recipient cows by non-surgical methods, about 30E of these embryos resulted in pregnancies.
Claims
WHAT IS CLAIMED IS:
1. A method to culture bovine embryos in vitro comprising steps of
a) collecting early stage embryos;
b) placing the early stage embryos in a suspension
culture system of buffered balanced salt solution
with a carbohydrate energy source medium and boine
oviductal epithelial cells;
c) holding the suspension system at about 38"C and
about 5 CO2 and 95% air humidified atmosphere; and
d) culturing the embryos until morula or blastocyst
stage.
2. A method to culture bovine embryos in vitro of claim 1 wherein 1n step (a) the examining of the early stage embryos and selecting 1- to 2-cell embryos for culturing.
3. A method to culture bovine embryos of claim 1 including the step of transferring the cultured embryo to a recipient cow.
4. A method to culture bovine embryos of claim 1 including the step of covering the suspension system under a ilm after step (b).
5. A method to culture bovine embryos in vitro comprising the steps of
a) collecting early stage embryos;
b) placing the embryos in a mixture of bovine or
ovine oviductal fluid, buffered balanced
salt solution with a carbohydrate enter source
medium and bovine oviductal epithelial cells
in a suspension system;
c) holding the suspension system at about 3E C and
about 5 CO2 and 95% air humidified atmosphere; and
d) culturing the embryos until morula or blastocyst
stage.
C. A method to culture bovine embryos in vitro of Claim 5 including the step of transferring the cultured embryo to a recipient cow.
7. A method to culture bovine embryos of Claim 5 including the step of covering the suspension system under a film after step (b) 8. A method to culture bovine embryos in vitro comprising the steps of
a) collecting early stage embryos;
b) placing the embryos in a mixture of bovine or
ovine oviductal fluid, buffered balanced
salt solution with a carbohydrate energy source
medium supplemented with amino acids and bovine
oviductal epithelial cells in a suspension system;
c) holding the suspension sstem at about 38"C and
about 5% C02 and 95 air humidified atmosphere; and
culturing the embryos until morula or blastocyst
stage.
9. An in vitro culture system for bovine embryos comprisIng a mixture of a buffered balanced salt solution with a carbohydrate energy source and bovine oviductal epithelial cells in a suspension system.
10. An in vitro culture system of bovine embryos of claim 9 whereIn said buffered balanced salt solution with carbohydrate energy source is suppleiiiented with amino acids.
11. An in vitro culture system for bovine embryos comprising a mixture of a buffered balanced salt solution with a carbohydrate energy source with oviductal fluid selected from the group of bovine or ovine and oviductal epithelial cells in 2 suspension system.
12. An in vitro culture system for bovine embryos of claim 11 wherein the buffered balanced salt solution with a carbohydrate energy source medium and oviductal fluid is in a 1:1 mixture.
13. An in vitro culture system for bovine embryos of claim 11 wherein the oviductal epithelial cells are about 5% to 15 volume of the fluid medina.
14. An in vitro culture system for bovine embryos of claim 11 wherein the buffered balanced salt solution with a carbohydrate energy source is supplemented with amino acids.
15. An in vitro culture system for bovine embryos of claim 11 wherein said buffered balanced salt solution with carbohydrate energy source is supplemented with amino acids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14942788A | 1988-01-29 | 1988-01-29 | |
US149,427 | 1988-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1989007135A1 true WO1989007135A1 (en) | 1989-08-10 |
Family
ID=22530228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1988/004700 WO1989007135A1 (en) | 1988-01-29 | 1988-12-29 | Bovine embryo in vitro culture |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0398979A1 (en) |
JP (1) | JPH03503841A (en) |
AU (1) | AU3068089A (en) |
CA (1) | CA1319122C (en) |
IE (1) | IE890289L (en) |
IL (1) | IL88863A0 (en) |
NZ (1) | NZ227701A (en) |
WO (1) | WO1989007135A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0417743A1 (en) * | 1989-09-11 | 1991-03-20 | Ajinomoto Co., Inc. | Cleavage promoter |
US5160312A (en) * | 1990-02-09 | 1992-11-03 | W. R. Grace & Co.-Conn. | Cryopreservation process for direct transfer of embryos |
US5418159A (en) * | 1989-01-10 | 1995-05-23 | Amrad Corporation Limited | Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
US5633076A (en) * | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
CN112760225A (en) * | 2021-01-27 | 2021-05-07 | 西北农林科技大学 | Bovine embryo in-vitro early implantation culture system |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE881133L (en) * | 1988-04-14 | 1989-10-14 | Univ Dublin | In-vitro culture of bovine embryos |
-
1988
- 1988-12-29 JP JP1502375A patent/JPH03503841A/en active Pending
- 1988-12-29 AU AU30680/89A patent/AU3068089A/en not_active Abandoned
- 1988-12-29 EP EP89902494A patent/EP0398979A1/en not_active Withdrawn
- 1988-12-29 WO PCT/US1988/004700 patent/WO1989007135A1/en not_active Application Discontinuation
-
1989
- 1989-01-02 IL IL88863A patent/IL88863A0/en unknown
- 1989-01-09 CA CA000587757A patent/CA1319122C/en not_active Expired - Fee Related
- 1989-01-24 NZ NZ227701A patent/NZ227701A/en unknown
- 1989-01-30 IE IE890289A patent/IE890289L/en unknown
Non-Patent Citations (4)
Title |
---|
J. REPRODUCTION AND FERTILITY, Vol. 30, 1972, H.R. TERVIT et al., "Successful Culture in Vitro of Sheep and Cattle Ova", pages 493-497. * |
J. REPRODUCTION AND FERTILITY, Vol. 72, No. 2, 1984, Journals of Reproduction and Fertility Ltd, S. CAMOUS et al., "Cleavage Beyond the Block Stage and Survival After Transfer of Early Bovine Embryos Cultured with Trophoblastic Vesicles", pages 479-485. * |
J. REPRODUCTION AND FERTILITY, Vol. 81, No. 1, 1987, F. GANDOLFI et al., "Stimulation of Early Embryonic Development in the Sheep by Co-Culture with Oviduct Epithelial Cells", pages 23-28. * |
THERIOGENOLOGY, Vol. 27, No. 1, 1987, W.H. EYESTONE et al., "Co-Culture of Early Bovine Embryos with Oviductal Epithelium", page 228. * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5418159A (en) * | 1989-01-10 | 1995-05-23 | Amrad Corporation Limited | Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
EP0417743A1 (en) * | 1989-09-11 | 1991-03-20 | Ajinomoto Co., Inc. | Cleavage promoter |
US5206160A (en) * | 1989-09-11 | 1993-04-27 | Ajinomoto Company, Inc. | Composition containing buf-3 and superoxide dismutase as a cell cleavage promoting agent |
US5633076A (en) * | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
US5741957A (en) * | 1989-12-01 | 1998-04-21 | Pharming B.V. | Transgenic bovine |
US6013857A (en) * | 1989-12-01 | 2000-01-11 | Pharming B.V. | Transgenic bovines and milk from transgenic bovines |
US5160312A (en) * | 1990-02-09 | 1992-11-03 | W. R. Grace & Co.-Conn. | Cryopreservation process for direct transfer of embryos |
CN112760225A (en) * | 2021-01-27 | 2021-05-07 | 西北农林科技大学 | Bovine embryo in-vitro early implantation culture system |
Also Published As
Publication number | Publication date |
---|---|
CA1319122C (en) | 1993-06-15 |
JPH03503841A (en) | 1991-08-29 |
IE890289L (en) | 1989-07-29 |
NZ227701A (en) | 1991-12-23 |
EP0398979A1 (en) | 1990-11-28 |
AU3068089A (en) | 1989-08-25 |
IL88863A0 (en) | 1989-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5096822A (en) | Bovine embryo medium | |
Biggers | Pioneering mammalian embryo culture | |
Moore et al. | Glycine and alanine supplementation of culture medium enhances development of in vitro matured and fertilized cattle embryos | |
Wright Jr et al. | Aspects of in vitro fertilization and embryo culture in domestic animals | |
US20090191534A1 (en) | System and sequential culture media for in vitro fertilization | |
Lee et al. | Synergistic effect of alanine and glycine on bovine embryos cultured in a chemically defined medium and amino acid uptake by in vitro-produced bovine morulae and blastocysts | |
Hochi et al. | Effect of linoleic acid-albumin in the culture medium on freezing sensitivity of in vitro-produced bovine morulae | |
Diez et al. | Delipidating in vitro-produced bovine zygotes: effect on further development and consequences for freezability | |
US5213979A (en) | In vitro culture of bovine embryos | |
US20180355312A1 (en) | Methods, media and products for culturing embryos | |
Chian et al. | Fertilization and early cleavage in vitro of ageing bovine oocytes after maturation in culture | |
Fukui et al. | Fertilizability and developmental capacity of individually cultured bovine oocytes | |
Mizushima et al. | Fertilizability and developmental capacity of bovine oocytes cultured individually in a chemically defined maturation medium | |
WO1989007135A1 (en) | Bovine embryo in vitro culture | |
Utsumi et al. | Full-term development of bovine follicular oocytes matured in culture and fertilized in vitro | |
Pope | Thirty years of assisted reproductive technology in the domestic cat: A selected summary | |
Staigmiller | In vitro methods for production of viable oocytes | |
Singina | Change of culture medium positively influences the development and quality of in vitro cattle embryos | |
Monis et al. | Development of four-cell hamster embryos to the blastocyst stage in vitro and its regulation by components of the culture milieu | |
Mermillod | In vitro production of ruminant embryos: results, limits and perspectives | |
JP2010507373A (en) | Method for isolating pluripotent cells from preimplantation embryos in medium without animal serum | |
Jura et al. | In vitro and in vivo development of bovine embryos from zygotes and 2-cell embryos microinjected with exogenous DNA | |
Nagashima et al. | In vitro development of in vivo and in vitro fertilized porcine zygotes | |
Thomas et al. | Method for producing transgenic bovine embryos from in vitro matured and fertilized oocytes | |
Petters | Embryo development in vitro to the blastocyst stage in cattle, pigs and sheep |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989902494 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989902494 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989902494 Country of ref document: EP |